Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer.
Hall
M
M
Molecular Oncology Laboratory, Imperial Cancer Research Fund, London, United Kingdom.
Peters
G
G
D002453:Cell Cycle / Q000235:genetics; D019938:Cyclin D1; D018844:Cyclin-Dependent Kinases / Q000037:antagonists & inhibitors / Q000235:genetics*; D016213:Cyclins / Q000235:genetics*; D004791:Enzyme Inhibitors / Q000378:metabolism*; D006801:Humans; D009154:Mutation; D009369:Neoplasms / Q000235:genetics* / Q000378:metabolism; D015513:Oncogene Proteins / Q000235:genetics; D014178:Translocation, Genetic
D016213:Cyclins; D004791:Enzyme Inhibitors; D015513:Oncogene Proteins; D019938:Cyclin D1; D018844:Cyclin-Dependent Kinases